Trial: 202003124

Adjuvant pembrolizumab and hypofractionated radiation therapy for the treatment of mucosal melanoma

Phase

II

Principal Investigator

Ansstas, George

Disease Site

Melanoma, Skin

Learn more about this study at: clinicaltrials.gov